当前位置:首页 - 行情中心 - 苑东生物(688513) - 财务分析 - 现金流量表

苑东生物

(688513)

  

流通市值:103.94亿  总市值:103.94亿
流通股本:1.77亿   总股本:1.77亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金740,212,954.98363,135,826.361,423,588,372.39965,538,169.27
  收到的税费返还44,867.2514,955.7511,618,077.872,644,605.92
  收到其他与经营活动有关的现金42,655,401.2415,447,523.86115,564,853.0658,850,016.33
  经营活动现金流入小计782,913,223.47378,598,305.971,550,771,303.321,027,032,791.52
  购买商品、接受劳务支付的现金120,227,395.0159,460,936.29272,424,977.15161,934,143.81
  支付给职工以及为职工支付的现金177,142,813.26103,426,617.83299,121,565.59233,163,044.14
  支付的各项税费72,084,393.331,992,808.24158,666,814.46101,485,163.59
  支付其他与经营活动有关的现金255,985,963.4134,760,143.84557,317,576.87383,803,669.95
  经营活动现金流出小计625,440,564.97329,640,506.21,287,530,934.07880,386,021.49
  经营活动产生的现金流量净额157,472,658.548,957,799.77263,240,369.25146,646,770.03
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额1,370,128.38-493,869.86119,724.41
  收到的其他与投资活动有关的现金614,130,682.91281,557,404.752,251,187,606.141,275,286,120.56
  投资活动现金流入小计615,500,811.29281,557,404.752,251,681,4761,275,405,844.97
  购建固定资产、无形资产和其他长期资产支付的现金32,724,421.8312,267,277.9117,423,923.0591,306,453.66
  投资支付的现金--1,500,0001,500,000
  支付其他与投资活动有关的现金880,698,104.99820,598,104.991,936,126,6251,338,833,055.56
  投资活动现金流出小计913,422,526.82832,865,382.892,055,050,548.051,431,639,509.22
  投资活动产生的现金流量净额-297,921,715.53-551,307,978.14196,630,927.95-156,233,664.25
三、筹资活动产生的现金流量:
  吸收投资收到的现金9,536,983.68-34,759,466.9734,695,540
  取得借款收到的现金35,000,00010,000,000150,000,000100,000,000
  收到其他与筹资活动有关的现金85,477,714.8743,275,359.969,999,987.557,753,247.94
  筹资活动现金流入小计130,014,698.5553,275,359.96194,759,454.47192,448,787.94
  偿还债务支付的现金71,466,666.6720,000,000253,923,333.34172,456,666.67
  分配股利、利润或偿付利息支付的现金76,151,625.18672,983.3674,107,631.673,301,105.85
  支付其他与筹资活动有关的现金4,454,116.424,454,116.42128,993,902.4122,163,055.14
  筹资活动现金流出小计152,072,408.2725,127,099.78457,024,867.34367,920,827.66
  筹资活动产生的现金流量净额-22,057,709.7228,148,260.18-262,265,412.87-175,472,039.72
四、汇率变动对现金及现金等价物的影响2,612.2318,950.7631,963.75-237,046.52
五、现金及现金等价物净增加额-162,504,154.52-474,182,967.43197,637,848.08-185,295,980.46
  加:期初现金及现金等价物余额965,178,505.19965,178,505.19767,540,657.11767,540,657.11
  期末现金及现金等价物余额802,674,350.67490,995,537.76965,178,505.19582,244,676.65
补充资料:
  净利润136,571,926.08-238,234,159.3-
  资产减值准备1,079,831.19-5,698,289.79-
  固定资产和投资性房地产折旧40,141,829.21-80,612,312.26-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧40,141,829.21-80,612,312.26-
  无形资产摊销1,212,076.2-2,223,734.26-
  长期待摊费用摊销636,069.74-1,674,586.29-
  处置固定资产、无形资产和其他长期资产的损失--2,992.06-
  固定资产报废损失20,983.86-109,753.41-
  公允价值变动损失-6,835,167.13--14,923,057.38-
  财务费用1,275,243.07-3,616,074.27-
  投资损失-4,047,937.64--9,841,891.62-
  递延所得税1,850,656.37--2,686,136.69-
  其中:递延所得税资产减少1,339,583.11--2,933,751.18-
    递延所得税负债增加511,073.26-247,614.49-
  存货的减少-25,638,050.98--34,803,016.51-
  经营性应收项目的减少28,915,103.3--112,437,411.52-
  经营性应付项目的增加-33,109,363.55-82,731,163.18-
  其他14,886,582.65-19,976,151.87-
  现金的期末余额802,674,350.67-965,178,505.19-
  减:现金的期初余额965,178,505.19-767,540,657.11-
  现金及现金等价物的净增加额-162,504,154.52-197,637,848.08-
公告日期2025-08-192025-04-252025-04-252024-10-25
审计意见(境内)标准无保留意见
TOP↑